{
  "symbol": "BOWNU",
  "company_name": "Bowen Acquisition Corp",
  "ir_website": "https://www.bowenspac.com/",
  "structured_data": [
    {
      "section_name": "Investor Relations",
      "links": [
        {
          "title": "Investor Relations Overview",
          "url": "https://www.bowenspac.com/investor-relations",
          "content": "top of page\n\n![bowen logo.png](https://static.wixstatic.com/media/84c14f_75101779184041ceb6993afc98e72138~mv2.png/v1/crop/x_293,y_0,w_1514,h_1592/fill/w_87,h_91,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/bowen%20logo.png)\n\n## [BOWEN](https://www.bowenspac.com) [ACQUISITION](https://www.bowenspac.com)\n\n## INVESTOR RELATIONS\n\n# PRESS RELEASES\n\n24/1/19\n\nBowen Acquisition Corp Announces Entering into Merger Agreement with Shenzhen Qianzhi BioTech Company\n\n[Read More](https://www.bowenspac.com/news/bowen-acquisition-corp-announces-entering-into-merger-agreement-with-shenzhen-qianzhi-biotech-company)\n\n23/7/31\n\nBowen Acquisition Corp Announces Closing of Full Over-Allotment Option\n\n[Read More](https://www.bowenspac.com/news/bowen-acquisition-corp-announces-closing-of-full-over-allotment-option)\n\n23/7/17\n\nBowen Acquisition Corp Announces Closing of $60,000,000 Initial Public Offering\n\n[Read More](https://www.bowenspac.com/news/bowen-acquisition-corp-announces-closing-of-%2460%2C000%2C000-initial-public-offering)\n\n# GOVERNANCE DOCUMENTS\n\n## [Audit Committee Charter](https://www.bowenspac.com/_files/ugd/84c14f_6fc7c65040a143829774985743f9261e.pdf)\n\n## [Compensation Committee Charter](https://www.bowenspac.com/_files/ugd/84c14f_f488af69b1564bcb9aee6b8b8ea096c5.pdf)\n\n## [Code of Ethics](https://www.bowenspac.com/_files/ugd/84c14f_1a549e8622eb416daa27ab32473d0431.pdf)\n\n## [Nominating Committee Charter](https://www.bowenspac.com/_files/ugd/84c14f_ea8fd2003b114edcb8fbc21d688fae93.pdf)\n\n## SEC FILINGS\n\nAll filings for Bowen Acquisition available via EDGAR.\n\n[View All Filings](https://www.sec.gov/edgar/browse/?CIK=1973056&owner=exclude)\n\nbottom of page\n"
        },
        {
          "title": "Financial Reports",
          "url": "https://www.bowenspac.com/investor-relations/financial-reports",
          "content": "top of page\n\n![bowen logo.png](https://static.wixstatic.com/media/84c14f_75101779184041ceb6993afc98e72138~mv2.png/v1/crop/x_293,y_0,w_1514,h_1592/fill/w_87,h_91,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/bowen%20logo.png)\n\n## [BOWEN](https://www.bowenspac.com) [ACQUISITION](https://www.bowenspac.com)\n\n## INVESTOR RELATIONS\n\n# PRESS RELEASES\n\n24/1/19\n\nBowen Acquisition Corp Announces Entering into Merger Agreement with Shenzhen Qianzhi BioTech Company\n\n[Read More](https://www.bowenspac.com/news/bowen-acquisition-corp-announces-entering-into-merger-agreement-with-shenzhen-qianzhi-biotech-company)\n\n23/7/31\n\nBowen Acquisition Corp Announces Closing of Full Over-Allotment Option\n\n[Read More](https://www.bowenspac.com/news/bowen-acquisition-corp-announces-closing-of-full-over-allotment-option)\n\n23/7/17\n\nBowen Acquisition Corp Announces Closing of $60,000,000 Initial Public Offering\n\n[Read More](https://www.bowenspac.com/news/bowen-acquisition-corp-announces-closing-of-%2460%2C000%2C000-initial-public-offering)\n\n# GOVERNANCE DOCUMENTS\n\n![](https://static.wixstatic.com/media/40d80b8089c8418a961cb75d96d491f7.png/v1/fill/w_35,h_47,al_c,q_85,usm_0.66_1.00_0.01,enc_auto/40d80b8089c8418a961cb75d96d491f7.png)\n\n## [Audit Committee Charter](https://www.bowenspac.com/_files/ugd/84c14f_6fc7c65040a143829774985743f9261e.pdf)\n\n![](https://static.wixstatic.com/media/40d80b8089c8418a961cb75d96d491f7.png/v1/fill/w_35,h_47,al_c,q_85,usm_0.66_1.00_0.01,enc_auto/40d80b8089c8418a961cb75d96d491f7.png)\n\n## [Compensation Committee Charter](https://www.bowenspac.com/_files/ugd/84c14f_f488af69b1564bcb9aee6b8b8ea096c5.pdf)\n\n![](https://static.wixstatic.com/media/40d80b8089c8418a961cb75d96d491f7.png/v1/fill/w_35,h_47,al_c,q_85,usm_0.66_1.00_0.01,enc_auto/40d80b8089c8418a961cb75d96d491f7.png)\n\n## [Code of Ethics](https://www.bowenspac.com/_files/ugd/84c14f_1a549e8622eb416daa27ab32473d0431.pdf)\n\n![](https://static.wixstatic.com/media/40d80b8089c8418a961cb75d96d491f7.png/v1/fill/w_35,h_47,al_c,q_85,usm_0.66_1.00_0.01,enc_auto/40d80b8089c8418a961cb75d96d491f7.png)\n\n## [Nominating Committee Charter](https://www.bowenspac.com/_files/ugd/84c14f_ea8fd2003b114edcb8fbc21d688fae93.pdf)\n\n## SEC FILINGS\n\nAll filings for Bowen Acquisition available via EDGAR.\n\n[View All Filings](https://www.sec.gov/edgar/browse/?CIK=1973056&owner=exclude)\n\nbottom of page\n"
        },
        {
          "title": "Press Releases",
          "url": "https://www.bowenspac.com/investor-relations/press-releases",
          "content": "top of page\n\n![bowen logo.png](https://static.wixstatic.com/media/84c14f_75101779184041ceb6993afc98e72138~mv2.png/v1/crop/x_293,y_0,w_1514,h_1592/fill/w_87,h_91,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/bowen%20logo.png)\n\n## [BOWEN](https://www.bowenspac.com) [ACQUISITION](https://www.bowenspac.com)\n\n## INVESTOR RELATIONS\n\n# PRESS RELEASES\n\n24/1/19\n\nBowen Acquisition Corp Announces Entering into Merger Agreement with Shenzhen Qianzhi BioTech Company\n\n[Read More](https://www.bowenspac.com/news/bowen-acquisition-corp-announces-entering-into-merger-agreement-with-shenzhen-qianzhi-biotech-company)\n\n23/7/31\n\nBowen Acquisition Corp Announces Closing of Full Over-Allotment Option\n\n[Read More](https://www.bowenspac.com/news/bowen-acquisition-corp-announces-closing-of-full-over-allotment-option)\n\n23/7/17\n\nBowen Acquisition Corp Announces Closing of $60,000,000 Initial Public Offering\n\n[Read More](https://www.bowenspac.com/news/bowen-acquisition-corp-announces-closing-of-%2460%2C000%2C000-initial-public-offering)\n\n# GOVERNANCE DOCUMENTS\n\n![](https://static.wixstatic.com/media/40d80b8089c8418a961cb75d96d491f7.png/v1/fill/w_35,h_47,al_c,q_85,usm_0.66_1.00_0.01,enc_auto/40d80b8089c8418a961cb75d96d491f7.png)\n\n## [Audit Committee Charter](https://www.bowenspac.com/_files/ugd/84c14f_6fc7c65040a143829774985743f9261e.pdf)\n\n![](https://static.wixstatic.com/media/40d80b8089c8418a961cb75d96d491f7.png/v1/fill/w_35,h_47,al_c,q_85,usm_0.66_1.00_0.01,enc_auto/40d80b8089c8418a961cb75d96d491f7.png)\n\n## [Compensation Committee Charter](https://www.bowenspac.com/_files/ugd/84c14f_f488af69b1564bcb9aee6b8b8ea096c5.pdf)\n\n![](https://static.wixstatic.com/media/40d80b8089c8418a961cb75d96d491f7.png/v1/fill/w_35,h_47,al_c,q_85,usm_0.66_1.00_0.01,enc_auto/40d80b8089c8418a961cb75d96d491f7.png)\n\n## [Code of Ethics](https://www.bowenspac.com/_files/ugd/84c14f_1a549e8622eb416daa27ab32473d0431.pdf)\n\n![](https://static.wixstatic.com/media/40d80b8089c8418a961cb75d96d491f7.png/v1/fill/w_35,h_47,al_c,q_85,usm_0.66_1.00_0.01,enc_auto/40d80b8089c8418a961cb75d96d491f7.png)\n\n## [Nominating Committee Charter](https://www.bowenspac.com/_files/ugd/84c14f_ea8fd2003b114edcb8fbc21d688fae93.pdf)\n\n## SEC FILINGS\n\nAll filings for Bowen Acquisition available via EDGAR.\n\n[View All Filings](https://www.sec.gov/edgar/browse/?CIK=1973056&owner=exclude)\n\nbottom of page\n"
        },
        {
          "title": "Shareholder Information",
          "url": "https://www.bowenspac.com/investor-relations/shareholder-info",
          "content": "top of page\n\n![bowen logo.png](https://static.wixstatic.com/media/84c14f_75101779184041ceb6993afc98e72138~mv2.png/v1/crop/x_293,y_0,w_1514,h_1592/fill/w_87,h_91,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/bowen%20logo.png)\n\n## [BOWEN](https://www.bowenspac.com) [ACQUISITION](https://www.bowenspac.com)\n\n## INVESTOR RELATIONS\n\n# PRESS RELEASES\n\n24/1/19\n\nBowen Acquisition Corp Announces Entering into Merger Agreement with Shenzhen Qianzhi BioTech Company\n\n[Read More](https://www.bowenspac.com/news/bowen-acquisition-corp-announces-entering-into-merger-agreement-with-shenzhen-qianzhi-biotech-company)\n\n23/7/31\n\nBowen Acquisition Corp Announces Closing of Full Over-Allotment Option\n\n[Read More](https://www.bowenspac.com/news/bowen-acquisition-corp-announces-closing-of-full-over-allotment-option)\n\n23/7/17\n\nBowen Acquisition Corp Announces Closing of $60,000,000 Initial Public Offering\n\n[Read More](https://www.bowenspac.com/news/bowen-acquisition-corp-announces-closing-of-%2460%2C000%2C000-initial-public-offering)\n\n# GOVERNANCE DOCUMENTS\n\n![](https://static.wixstatic.com/media/40d80b8089c8418a961cb75d96d491f7.png/v1/fill/w_35,h_47,al_c,q_85,usm_0.66_1.00_0.01,enc_auto/40d80b8089c8418a961cb75d96d491f7.png)\n\n## [Audit Committee Charter](https://www.bowenspac.com/_files/ugd/84c14f_6fc7c65040a143829774985743f9261e.pdf)\n\n![](https://static.wixstatic.com/media/40d80b8089c8418a961cb75d96d491f7.png/v1/fill/w_35,h_47,al_c,q_85,usm_0.66_1.00_0.01,enc_auto/40d80b8089c8418a961cb75d96d491f7.png)\n\n## [Compensation Committee Charter](https://www.bowenspac.com/_files/ugd/84c14f_f488af69b1564bcb9aee6b8b8ea096c5.pdf)\n\n![](https://static.wixstatic.com/media/40d80b8089c8418a961cb75d96d491f7.png/v1/fill/w_35,h_47,al_c,q_85,usm_0.66_1.00_0.01,enc_auto/40d80b8089c8418a961cb75d96d491f7.png)\n\n## [Code of Ethics](https://www.bowenspac.com/_files/ugd/84c14f_1a549e8622eb416daa27ab32473d0431.pdf)\n\n![](https://static.wixstatic.com/media/40d80b8089c8418a961cb75d96d491f7.png/v1/fill/w_35,h_47,al_c,q_85,usm_0.66_1.00_0.01,enc_auto/40d80b8089c8418a961cb75d96d491f7.png)\n\n## [Nominating Committee Charter](https://www.bowenspac.com/_files/ugd/84c14f_ea8fd2003b114edcb8fbc21d688fae93.pdf)\n\n## SEC FILINGS\n\nAll filings for Bowen Acquisition available via EDGAR.\n\n[View All Filings](https://www.sec.gov/edgar/browse/?CIK=1973056&owner=exclude)\n\nbottom of page\n"
        },
        {
          "title": "Contacts for Investor Relations",
          "url": "https://www.bowenspac.com/investor-relations/contact",
          "content": "top of page\n\n![bowen logo.png](https://static.wixstatic.com/media/84c14f_75101779184041ceb6993afc98e72138~mv2.png/v1/crop/x_293,y_0,w_1514,h_1592/fill/w_87,h_91,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/bowen%20logo.png)\n\n## [BOWEN](https://www.bowenspac.com) [ACQUISITION](https://www.bowenspac.com)\n\n## INVESTOR RELATIONS\n\n# PRESS RELEASES\n\n24/1/19\n\nBowen Acquisition Corp Announces Entering into Merger Agreement with Shenzhen Qianzhi BioTech Company\n\n[Read More](https://www.bowenspac.com/news/bowen-acquisition-corp-announces-entering-into-merger-agreement-with-shenzhen-qianzhi-biotech-company)\n\n23/7/31\n\nBowen Acquisition Corp Announces Closing of Full Over-Allotment Option\n\n[Read More](https://www.bowenspac.com/news/bowen-acquisition-corp-announces-closing-of-full-over-allotment-option)\n\n23/7/17\n\nBowen Acquisition Corp Announces Closing of $60,000,000 Initial Public Offering\n\n[Read More](https://www.bowenspac.com/news/bowen-acquisition-corp-announces-closing-of-%2460%2C000%2C000-initial-public-offering)\n\n# GOVERNANCE DOCUMENTS\n\n![](https://static.wixstatic.com/media/40d80b8089c8418a961cb75d96d491f7.png/v1/fill/w_35,h_47,al_c,q_85,usm_0.66_1.00_0.01,enc_auto/40d80b8089c8418a961cb75d96d491f7.png)\n\n## [Audit Committee Charter](https://www.bowenspac.com/_files/ugd/84c14f_6fc7c65040a143829774985743f9261e.pdf)\n\n![](https://static.wixstatic.com/media/40d80b8089c8418a961cb75d96d491f7.png/v1/fill/w_35,h_47,al_c,q_85,usm_0.66_1.00_0.01,enc_auto/40d80b8089c8418a961cb75d96d491f7.png)\n\n## [Compensation Committee Charter](https://www.bowenspac.com/_files/ugd/84c14f_f488af69b1564bcb9aee6b8b8ea096c5.pdf)\n\n![](https://static.wixstatic.com/media/40d80b8089c8418a961cb75d96d491f7.png/v1/fill/w_35,h_47,al_c,q_85,usm_0.66_1.00_0.01,enc_auto/40d80b8089c8418a961cb75d96d491f7.png)\n\n## [Code of Ethics](https://www.bowenspac.com/_files/ugd/84c14f_1a549e8622eb416daa27ab32473d0431.pdf)\n\n![](https://static.wixstatic.com/media/40d80b8089c8418a961cb75d96d491f7.png/v1/fill/w_35,h_47,al_c,q_85,usm_0.66_1.00_0.01,enc_auto/40d80b8089c8418a961cb75d96d491f7.png)\n\n## [Nominating Committee Charter](https://www.bowenspac.com/_files/ugd/84c14f_ea8fd2003b114edcb8fbc21d688fae93.pdf)\n\n## SEC FILINGS\n\nAll filings for Bowen Acquisition available via EDGAR.\n\n[View All Filings](https://www.sec.gov/edgar/browse/?CIK=1973056&owner=exclude)\n\nbottom of page\n"
        }
      ]
    }
  ]
}